Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Safety Study of the Administration of Bone Marrow Derived Stem Cells (ALD-451) in WHO Grade IV Malignant Glioma

NCT01639612 is registered in ClinicalTrials.gov with Henry Friedman as lead sponsor.

NCT NCT01639612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01639612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Safety Study of the Administration of Bone Marrow Derived Stem Cells (ALD-451) in WHO Grade IV Malignant Glioma
Lead sponsor
Henry Friedman
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2012
Completion date
April 30, 2016
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

grade iv malignant glioma